Sienna Biopharmaceuticals Garners $12,000,000 Series A Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b7c065d5-79c8-4ee0-8187-3037bdb933e2 - Date
7/13/2016 - Company Name
Sienna Biopharmaceuticals - Mailing Address
30721 Russell Ranch Road Westlake Village, CA 91362 USA - Company Description
Sienna Biopharmaceuticals is a company focused on the discovery, clinical development and commercialization of products in aesthetics and dermatology based on scientific breakthroughs that dramatically improve patient outcomes and physicians’ practice of medicine. - Website
http://www.siennabio.com - Transaction Type
Venture Equity - Transaction Amount
$12,000,000 - Transaction Round
Series A - Proceeds Purposes
The additional investment proceeds are targeted to fund Sienna’s pharmaceutical research and advance its business development efforts. Sienna’s lead proprietary technology, Silver Plasmonic Therapy (SPT) has promising applications for acne and permanent hair removal. Clinical trials are already underway and the Company is evaluating additional potential indications. - M&A Terms
- Venture Investor
ARCH Venture Partners - Venture Investor
Partner Fund Management - Venture Investor
Undisclosed
